Bluebird Bio reported $244M in Operating Expenses for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 89.22M 2M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 363.82M 6.04M
Amgen AMGN:US $ 3.77B 854M
Applied Genetic Technologies AGTC:US $ 14.49M 627K
Arrowhead Research ARWR:US $ 61.04M 15.69M
Biogen BIIB:US $ 2289.3M 569.2M
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Bluebird Bio BLUE:US $ 244M 29.31M
Dicerna Pharmaceuticals DRNA:US $ 76.71M 4.1M
Gilead Sciences GILD:US $ 3971M 438M
Immunogen IMGN:US $ 44.32M 305K
Intercept Pharmaceuticals ICPT:US $ 95.82M 15.19M
IONIS PHARMACEUT IONS:US $ 203.58M 109.37M
Mirati Therapeutics MRTX:US $ 132.42M 24.38M
Moderna Inc MRNA:US 671M 174.78M
Nektar Therapeutics NKTR:US $ 133.04M 1.14M
Novartis NOVN:VX 10.28B 107M
Pfizer PFE:US $ 13063M 3998M
Ptc Therapeutics PTCT:US $ 215.17M 921K
Regeneron Pharmaceuticals REGN:US $ 1416M 160.1M
Sangamo Biosciences SGMO:US $ 72.58M 3.35M
Sarepta Therapeutics SRPT:US $ 298.8M 17.06M
Seattle Genetics SGEN:US $ 478.08M 23.68M
Ultragenyx Pharmaceutical RARE:US $ 205.96M 18.34M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
YTE INCY:US $ 505.92M 119.36M